J. Goldman & Co »

Vaneck Vectors Pharmaceutical etf shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.1M 38k 81.37
2021-03-31 $3.1M 45k 68.93
2020-12-31 $4.4M 67k 66.42
2020-09-30 $5.7M 92k 62.16

More positions owned by J. Goldman & Co

Paypal Holdings (PYPL)
Advisorshares Tr Pure Us Cannabis (MSOS)
Microsoft Corporation (MSFT)
Lowe's Companies (LOW)
Spotify Technology S A SHS (SPOT)
Tko Group Holdings Cl A (TKO)
Regeneron Pharmaceuticals (REGN)
Select Sector Spdr Tr Technology (XLK)
Norfolk Southern (NSC)
Dollar Tree (DLTR)
Rivian Automotive Com Cl A (RIVN)
Eli Lilly & Co. (LLY)
Canadian Pacific Kansas City (CP)
Hasbro (HAS)
MDU Resources (MDU)

View all positions for J. Goldman & Co

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf